Massmutual Trust CO Fsb Indaptus Therapeutics, Inc. Transaction History
Massmutual Trust CO Fsb
- $3.28 Billion
- Q2 2024
A detailed history of Massmutual Trust CO Fsb transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 14 shares of INDP stock, worth $21. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14Holding current value
$21% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INDP
# of Institutions
21Shares Held
600KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$386,9600.0% of portfolio
-
Investment House LLC Las Vegas, NV102KShares$154,6790.01% of portfolio
-
Geode Capital Management, LLC Boston, MA59.3KShares$89,5560.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$68,4570.02% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ44.1KShares$66,5680.01% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $12.5M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...